Literature DB >> 11408072

DNA copy number changes in familial malignant mesothelioma.

V Ascoli1, Y Aalto, C Carnovale-Scalzo, F Nardi, D Falzetti, C Mecucci, S Knuutila.   

Abstract

Malignant mesothelioma (MM) is predominantly a sporadic malignancy linked to exposure to asbestos. Clustering of MM in families suggests genetic susceptibility as a contributing factor. We performed comparative genomic hybridization (CGH) analysis on tumor samples from members of a family with MM of the pleura and a history of parental cancer. Our specific aim was to find a recurrent copy number loss indicating the chromosomal area to which a gene underlying the development of MM could be assigned according to the Knudson two-hit hypothesis. We found losses at 1p, 6q, 9p, 13q, and 14q. The copy number changes were very similar to those reported in sporadic cases. Our findings and results from sporadic cases highlight the importance of cloning the genes in the loss sites at 1p, 6q, 14q, and 22q.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408072     DOI: 10.1016/s0165-4608(00)00420-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  A one-generation cluster of malignant mesothelioma within a family reveals exposure to asbestos-contaminated jute bags in Naples, Italy.

Authors:  V Ascoli; C Carnovale-Scalzo; F Nardi; C Efrati; M Menegozzo
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Comparative genomic hybridisation in malignant deciduoid mesothelioma.

Authors:  A Scattone; A Pennella; M Gentile; M Musti; P Nazzaro; A L Buonadonna; A Marzullo; D Cavone; L Pollice; G Serio
Journal:  J Clin Pathol       Date:  2006-03-28       Impact factor: 3.411

3.  An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.

Authors:  Mitchell Cheung; Yuwaraj Kadariya; Jianming Pei; Jacqueline Talarchek; Francesco Facciolo; Paolo Visca; Luisella Righi; Ilaria Cozzi; Joseph R Testa; Valeria Ascoli
Journal:  Cancer Genet       Date:  2015-07-30

Review 4.  Current therapy for malignant mesothelioma.

Authors:  W Roy Smythe
Journal:  Curr Oncol Rep       Date:  2002-07       Impact factor: 5.945

5.  Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines.

Authors:  Penny Nymark; Pamela M Lindholm; Mikko V Korpela; Leo Lahti; Salla Ruosaari; Samuel Kaski; Jaakko Hollmén; Sisko Anttila; Vuokko L Kinnula; Sakari Knuutila
Journal:  BMC Genomics       Date:  2007-03-01       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.